GREAT POINT PARTNERS LLC Quant / Systematic

CIK: 0001281446 · Show all filings

Period: Q2 2019 (← Previous) (Next →)

Filing Date: Aug 14, 2019

Total Value ($000): $900,806,000 (100.0% shares, 0.0% debt)

Holdings (30)

IOVA IOVANCE BIOTHERAPEUTICS, INC. 14.3%
Value ($000) $128,995,000 Shares 5,260,803 Est. Cost $9.91 Unrealized +52.0%
PTCT PTC THERAPEUTICS, INC. 9.9%
Value ($000) $88,847,000 Shares 1,974,385 Est. Cost $28.46 Unrealized +38.7%
ZOGENIX, INC. 8.5%
Value ($000) $76,132,000 Shares 1,593,396 Est. Cost $11839.82 Unrealized
AUDENTES THERAPEUTICS, INC. 8.1%
Value ($000) $72,802,000 Shares 1,922,937 Est. Cost $6914.70 Unrealized
KURA KURA ONCOLOGY, INC. 6.7%
Value ($000) $60,011,000 Shares 3,047,800 Est. Cost $12.67 Unrealized +31.0%
ACCELERON PHARMA INC 6.6%
Value ($000) $59,537,000 Shares 1,449,300 Est. Cost $18289.17 Unrealized
ASND ASCENDIS PHARMA AS 6.4%
Value ($000) $57,575,000 Shares 500,000 Est. Cost $19673.19 Unrealized
TRICIDA, INC. 6.2%
Value ($000) $56,191,000 Shares 1,423,998 Est. Cost $39460.03 Unrealized
ACAD ACADIA PHARMACEUTICALS, INC. 4.5%
Value ($000) $40,095,000 Shares 1,500,000 Est. Cost $18.73 Unrealized +36.4%
MIRATI THERAPEUTICS INC. 3.4%
Value ($000) $30,900,000 Shares 300,000 Est. Cost $103000.00 Unrealized
MIRATI THERAPEUTICS INC. 3.4%
Value ($000) $30,900,000 Shares 300,000 Est. Cost $103000.00 Unrealized
ZYMEWORKS INC. 2.6%
Value ($000) $23,409,000 Shares 1,064,041 Est. Cost $21698.24 Unrealized
RETROPHIN INC. 2.2%
Value ($000) $20,162,000 Shares 1,003,600 Est. Cost $20089.68 Unrealized
MIRATII THERAPEUTICS INC. 2.0%
Value ($000) $18,025,000 Shares 175,000 Est. Cost $103000.00 Unrealized
PRTA PROTHENA CORPORATION PLC 2.0%
Value ($000) $17,718,000 Shares 1,676,250 Est. Cost $10.27 Unrealized 0.0%
BIOHAVEN PHARMACEUTICAL HOLDING CO LTD. 1.7%
Value ($000) $15,327,000 Shares 350,000 Est. Cost $43791.43 Unrealized
MILLENDO THERAPEUTICS, INC. 1.7%
Value ($000) $14,891,000 Shares 1,288,093 Est. Cost $7.95 Unrealized
DERMIRA INC. 1.6%
Value ($000) $14,846,000 Shares 1,552,900 Est. Cost $338.76 Unrealized
ZOGENIX, INC. 1.6%
Value ($000) $14,334,000 Shares 300,000 Est. Cost $11839.82 Unrealized
GNFTY GENFIT 1.5%
Value ($000) $13,711,000 Shares 694,253 Est. Cost $24.00 Unrealized
MENLO THERAPEUTICS INC. 1.2%
Value ($000) $10,386,000 Shares 1,733,882 Est. Cost $7.51 Unrealized
BIOHAVEN PHARMACEUTICAL HOLDING CO. LTD. 1.0%
Value ($000) $8,758,000 Shares 200,000 Est. Cost $43791.43 Unrealized
FOAMIX PHARMACEUTICALS LTD 0.6%
Value ($000) $5,022,000 Shares 2,110,071 Est. Cost $7.50 Unrealized
IOVA IOVANCE BIOTHERAPETUICS, INC. 0.5%
Value ($000) $4,904,000 Shares 200,000 Est. Cost $9.91 Unrealized +52.0%
MOMENTA PHARMACEUTICALS, INC. 0.5%
Value ($000) $4,259,000 Shares 342,064 Est. Cost $1196.13 Unrealized
RVLPQ OSMOTICA PHARMACEUTICALS PLC 0.4%
Value ($000) $3,522,000 Shares 926,933 Est. Cost $8.00 Unrealized -58.5%
PROTEOSTASIS THERAPEUTICS INC. 0.4%
Value ($000) $3,416,000 Shares 3,500,000 Est. Cost $2.98 Unrealized
FIVE PRIME THERAPEUTICS, INC. 0.4%
Value ($000) $3,303,000 Shares 547,712 Est. Cost $6226.03 Unrealized
ZAFGEN INC. 0.3%
Value ($000) $2,631,000 Shares 2,211,194 Est. Cost $9.93 Unrealized
STREAMLINE HEALTH SOLUTNS, INC. 0.0%
Value ($000) $197,000 Shares 130,137 Est. Cost $6.45 Unrealized